HCPlive (1/14, Derman) reports, “A recent study suggested that the genetic variants in the opioid use disorder (OUD) risk algorithm do not meet reasonable standards in identifying OUD risk.” The researchers said, “We found no evidence to support the clinical utility of the 15 [single nucleotide variants] purported to predict OUD risk.” The findings were published in JAMA Network Open.
Related Links:
— “Genetic Variants in OUD Risk Algorithm Do Not Meet Standards in Identifying Risk,”Chelsie Derman, HCPlive, January 14, 2025